Postoperative Radioiodine Can Be Avoided in Patients with Low-Risk Differentiated Thyroid Cancer By Ogkologos - August 12, 2025 708 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the IoN study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR ESMO Targeted Anticancer Therapies Congress 2024, 26-28 February, Paris, France February 20, 2024 Should People Over Age 75 Be Screened for Colorectal Cancer? June 15, 2021 Breastfeeding Patterns and Relation to Breast Cancer Outcomes After Early, Hormone... July 23, 2025 Durvalumab Modestly Improves Survival in Advanced Biliary Tract Cancer February 10, 2022 Load more HOT NEWS Woman Uses Passion For Crocheting To Help Cancer Patients, The Homeless... New targeted lung cancer screening programme on the horizon Tepotinib Shows Activity in Advanced NSCLC with a MET Exon 14... Metastasis Likely Caused by Lack of Oxygen in Cancerous Tumors, Study...
